Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Antifungals susceptibility pattern of Candida spp. isolated from female genital tract at the Yaoundé Bethesda Hospital in Cameroon.

Kengne M, Shu SV, Nwobegahay JM, Achonduh O.

Pan Afr Med J. 2017 Dec 6;28:294. doi: 10.11604/pamj.2017.28.294.11200. eCollection 2017.

2.

[INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]

Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.

Akush Ginekol (Sofiia). 2016;55(4):20-29. Bulgarian.

PMID:
29370489
3.

In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).

Zida A, Yacouba A, Bamba S, Sangare I, Sawadogo M, Guiguemde T, Kone S, Traore LK, Ouedraogo-Traore R, Guiguemde RT.

J Mycol Med. 2017 Dec;27(4):469-475. doi: 10.1016/j.mycmed.2017.07.001. Epub 2017 Jul 25.

PMID:
28754462
4.

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.

Bitew A, Abebaw Y.

BMC Womens Health. 2018 Jun 15;18(1):94. doi: 10.1186/s12905-018-0607-z.

5.

In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.

Choukri F, Benderdouche M, Sednaoui P.

J Mycol Med. 2014 Dec;24(4):303-7. doi: 10.1016/j.mycmed.2014.05.001. Epub 2014 Oct 23.

PMID:
25442913
6.

Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates.

Brandolt TM, Klafke GB, Gonçalves CV, Bitencourt LR, Martinez AM, Mendes JF, Meireles MC, Xavier MO.

Braz J Microbiol. 2017 Jan - Mar;48(1):145-150. doi: 10.1016/j.bjm.2016.09.006. Epub 2016 Oct 4.

7.

[Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].

Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.

Rev Argent Microbiol. 2001 Oct-Dec;33(4):217-22. Spanish.

PMID:
11833253
8.
9.

Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.

Sojakova M, Liptajova D, Borovsky M, Subik J.

Mycopathologia. 2004 Feb;157(2):163-9.

PMID:
15119851
10.

[Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].

Diaz MC, Camponovo R, Araya I, Cerda A, Santander MP, Carrillo-Muñoz AJ.

Rev Esp Quimioter. 2016 Jun;29(3):151-4. Epub 2016 May 11. Spanish.

11.

Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.

Verghese S, Padmaja P, Asha M, Elizabeth SJ, Anitha A, Kundavi KM, Jayanthi N, Varma T.

Indian J Pathol Microbiol. 2001 Jul;44(3):313-4.

PMID:
12024920
12.

Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.

Liu XP, Fan SR, Peng YT, Zhang HP.

J Mycol Med. 2014 Jun;24(2):106-11. doi: 10.1016/j.mycmed.2014.01.060. Epub 2014 Apr 17.

PMID:
24746725
13.

Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates.

Güzel AB, Aydın M, Meral M, Kalkancı A, Ilkit M.

Infect Dis Obstet Gynecol. 2013;2013:698736. doi: 10.1155/2013/698736. Epub 2013 Dec 11.

14.

Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore.

Kwok YK, Tay YK, Goh CL, Kamarudin A, Koh MT, Seow CS.

Int J Dermatol. 1998 Feb;37(2):145-9.

PMID:
9542677
15.

[Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].

García Heredia M, García SD, Copolillo EF, Cora Eliseth M, Barata AD, Vay CA, de Torres RA, Tiraboschi N, Famiglietti AM.

Rev Argent Microbiol. 2006 Jan-Mar;38(1):9-12. Spanish.

PMID:
16784126
16.

Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China.

Shi XY, Yang YP, Zhang Y, Li W, Wang JD, Huang WM, Fan YM.

J Med Microbiol. 2015 Apr;64(Pt 4):390-3. doi: 10.1099/jmm.0.000024. Epub 2015 Jan 16.

PMID:
25596116
17.

Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis.

Lynch ME, Sobel JD, Fidel PL Jr.

J Med Vet Mycol. 1996 Sep-Oct;34(5):337-9.

PMID:
8912167
18.

[Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics].

Sojáková M, Liptajová D, Simoncicová M, Borovský M, Subík J.

Ceska Gynekol. 2003 Jan;68(1):24-9. Slovak.

PMID:
12708111
19.

Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.

Nagashima M, Yamagishi Y, Mikamo H.

J Infect Chemother. 2016 Feb;22(2):124-6. doi: 10.1016/j.jiac.2015.08.008. Epub 2015 Nov 25.

PMID:
26627336
20.

Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.

Theill L, Dudiuk C, Morano S, Gamarra S, Nardin ME, Méndez E, Garcia-Effron G.

Rev Argent Microbiol. 2016 Jan-Mar;48(1):43-9. doi: 10.1016/j.ram.2015.10.003. Epub 2016 Feb 26.

Supplemental Content

Support Center